NurExone Biologic Ltd
General Data
Reg Number
516209202
Sector
Biomed
Established
2020
No. of Employees
20
Stage
R&D
Additional Funding
0
Technology
ExoTherapy: A proprietary platform for developing exosome-Based therapies. Exosomes are nanosized extracellular vesicles with a natural ability to reach inflamed or damaged tissue. By loading exosomes with therapeutic compounds, nanodrugs are created having natural regenerative properties and therapeutic impact.
Targeted Customers
Physicians, People with spinal cord injuries and other Central Nervous System (CNS) traumatic injuries.
Management personnel
Lior Shaltiel - CEO
Eran Ovadya - CFO
Winning details
Route name
Winning year
R&D Fund
R&D Fund
2023